ANIDO ARMANDO (Chairman & Chief Exec. Officer) sold 1.9% of their position (17.83K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $23.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/14/2023ACC: 0001062993-23-018018
DirectorOfficer· Chairman & Chief Exec. Officer
Since Aug 2018
+46.92K
Net shares
Net buyer
$23.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
64.75K acquired · 17.83K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+64.75K
Price / share
—
Trade value
—
% of position
7.3%
9/12/2023
889.80K→954.55K
Common Stock
Direct
Shares
−17.83K
Price / share
$1.33
Trade value
$23.64K
% of position
1.9%
9/13/2023
954.55K→936.72K
Total
Net shares
+46.92K
Net value
-$23.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2023 | A · Award | +64.75K | — | — | 7.3% | 889.80K | 954.55K |
| Common Stock Direct | 9/13/2023 | S · Sale | −17.83K | $1.33 | $23.64K | 1.9% | 954.55K | 936.72K |
| Total | +46.92K | -$23.64K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned26.59K
Common Stock
IndirectShares owned13.30K
Total
39.89K indirect39.89K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.59K | Indirect |
| Common Stock | 13.30K | Indirect |
| Total | 39.89K | 39.89K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported